BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21919620)

  • 1. Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.
    Bassett JD; Swift SL; Bramson JL
    Expert Rev Vaccines; 2011 Sep; 10(9):1307-19. PubMed ID: 21919620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.
    Villacres MC; Zuo J; Bergmann CC
    Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination.
    Holst PJ; Ørskov C; Thomsen AR; Christensen JP
    J Immunol; 2010 Apr; 184(8):4431-9. PubMed ID: 20212099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination.
    Kaufman DR; Liu J; Carville A; Mansfield KG; Havenga MJ; Goudsmit J; Barouch DH
    J Immunol; 2008 Sep; 181(6):4188-98. PubMed ID: 18768876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming of CD8 T cells by adenoviral vectors is critically dependent on B7 and dendritic cells but only partially dependent on CD28 ligation on CD8 T cells.
    Nielsen KN; Steffensen MA; Christensen JP; Thomsen AR
    J Immunol; 2014 Aug; 193(3):1223-32. PubMed ID: 24951814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Virol; 2007 Sep; 81(18):10009-16. PubMed ID: 17609261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
    Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
    Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential outcome of IL-2/anti-IL-2 complex therapy on effector and memory CD8+ T cells following vaccination with an adenoviral vector encoding EBV epitopes.
    Smith C; Martinez M; Peet J; Khanna R
    J Immunol; 2011 May; 186(10):5784-90. PubMed ID: 21482735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
    Fitzgerald JC; Gao GP; Reyes-Sandoval A; Pavlakis GN; Xiang ZQ; Wlazlo AP; Giles-Davis W; Wilson JM; Ertl HC
    J Immunol; 2003 Feb; 170(3):1416-22. PubMed ID: 12538702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
    Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
    Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation.
    Steffensen MA; Holst PJ; Steengaard SS; Jensen BA; Bartholdy C; Stryhn A; Christensen JP; Thomsen AR
    J Virol; 2013 Jun; 87(11):6283-95. PubMed ID: 23536658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.
    Bassett JD; Yang TC; Bernard D; Millar JB; Swift SL; McGray AJ; VanSeggelen H; Boudreau JE; Finn JD; Parsons R; Evelegh C; Damjanovic D; Grinshtein N; Divangahi M; Zhang L; Xing Z; Wan Y; Bramson JL
    Blood; 2011 Jan; 117(4):1146-55. PubMed ID: 21088134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus.
    Suda T; Kawano M; Nogi Y; Ohno N; Akatsuka T; Matsui M
    Antiviral Res; 2011 Sep; 91(3):252-8. PubMed ID: 21722671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help.
    Estcourt MJ; McMichael AJ; Hanke T
    Eur J Immunol; 2005 Dec; 35(12):3460-7. PubMed ID: 16245361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
    Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG
    Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
    Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.